Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung Cancer
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
Progress Against Cancer
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to...
Supplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye...
More cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage...
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
First CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos...
Modified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.
Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma...
Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.
Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not...